[Press release] Bioplus contracts to supply “Blad-Care,” a treatment for cystitis. “First release completed” 2021년 December 30일 By bioplubiz
[Press release] Co-development MOU with BioPlus, Noblegen, and Gachon University for virus treatments was signed 2021년 December 23일 By bioplubiz
[Press release] Will BioPlus continue its surprise performance next year? It’s about to enter China, the biggest market 2021년 December 16일 By bioplubiz
[Press release] “BioPlus, Expectation for terraced growth due to business expansion” 2021년 December 3일 By bioplubiz
[Press release] BioPlus “Anti-adhesion drug, technology transfer with global companies” 2021년 November 26일 By bioplubiz
[Press release] “Manufacturing industry leader” investment attraction exceeded 100 trillion won (news report) 2021년 November 17일 By bioplubiz
[Press release] 1 trillion won of Hanwha Solution and 200 billion won of BioPlus investment 2021년 November 17일 By bioplubiz
[Press release] Bioplus got a product license from the Ministry of Food and Drug Safety for “Blad-Care”, a treatment for cystitis 2021년 November 17일 By bioplubiz
[Press release] Bioplus invested 3 billion won in Novelgen…Joint development of treatments 2021년 November 1일 By bioplubiz
